Article

2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 57, n° 4
pages 577-580 (octobre 2007)
Doi : 10.1016/j.jaad.2007.01.034
accepted : 25 January 2007
Reports

Cutaneous infiltration by cancer
 

Joaquim Marcoval, MD a, , Abelardo Moreno, MD b, Jordi Peyrí, MD a
a Department of Dermatology, Hospital de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain 
b Department of Pathology, Hospital de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain 

Reprint requests: Joaquim Marcoval, MD, Department of Dermatology, Hospital de Bellvitge, c/Feixa Llarga s/n, Hospitalet de Llobregat, 08907 Barcelona, Spain.
Abstract
Background

Cutaneous infiltration by cancer has been reported to occur in 0.7% to 9% of all patients with malignant neoplasms and is usually considered a late event in the evolution of most visceral carcinomas.

Objective

To analyze the clinicopathological features of cutaneous infiltration by cancer.

Methods

All biopsy specimens codified as cutaneous infiltration by cancer between 1988 and 2005 were retrieved. Patients with hematologic malignancies were excluded. The clinical charts of the patients were reviewed to obtain additional information.

Results

In all, 381 patients (136 male and 245 female) were included in the study. The most frequent primary tumors were breast carcinoma (168 cases), malignant melanoma (59 cases), mucosal carcinoma of the head and neck (34 cases), lung carcinoma (25 cases), and large intestine carcinoma (22 cases). The most frequent clinical presentations were solitary nodule in 153 cases, multiple nodules in 82 cases, and infiltration of surgical scars in 50 cases. In 128 patients (33.6%) the cutaneous infiltrative lesions were present at diagnosis of the primary tumor. The number of yearly specimens of infiltration by breast carcinoma increased significantly from the first half to the second half of the period under examination.

Limitations

This is an observational retrospective study.

Conclusions

With the possibility of determining prognostic factors by analyzing tissue samples from malignant tumors, the role of cutaneous biopsy is expected to become increasingly important in the management of oncology patients, as is already the case with breast carcinoma.

The full text of this article is available in PDF format.

 Funding sources: None.
 Conflicts of interest: None declared.



© 2007  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline